Advertisement
Document › Details
Agilent Technologies Inc.. (5/4/26). "Press Release: Agilent Names Michael Buckner as Chief Legal Officer". Santa Clara, CA.
Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today.
Buckner brings nearly three decades of experience as a senior global legal executive, with a proven track record of building and leading high-performing teams and deep expertise in complex transactions and regulatory environments.
“We are thrilled to welcome Michael to the Agilent team,” said Padraig McDonnell, Agilent president and CEO. “His experience leading global legal organizations, combined with his expertise across governance, compliance and regulatory matters, will play a key role as we continue to advance our strategy and deliver for our customers and stakeholders worldwide.”
Buckner joins Agilent from Danaher Corp., where he served as vice president, deputy general counsel, and chief M&A counsel. In this role, he led legal strategy for mergers and acquisitions, antitrust, intellectual property transactions, and debt securities, while overseeing a global team. He played a central role in several high-profile transactions, including the acquisition of Abcam and the Veralto spin-off, while advising senior leadership and members of the board on legal strategy and risk management.
Previously, Buckner spent 16 years at General Electric in roles of increasing responsibility, most recently as vice president and chief counsel for mergers and acquisitions, where he served as the company’s lead mergers and acquisitions lawyer globally. Earlier in his career, he held legal roles at Capital One Financial Corp. and in private practice, where he focused on corporate and securities law.
Buckner holds a Bachelor of Arts in history and political science, with high honors, from Rutgers University, and a Juris Doctor from the University of Chicago Law School.
About Agilent Technologies
Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.
Investor Contact
Tejas Savant
Agilent Technologies Inc.
+1 917-574-4018
tejas.savant@agilent.com
Media Contact
Kate Coyle
Agilent Technologies Inc.
+1 302-633-7490
kate.coyle@agilent.com
Record changed: 2026-05-18 |
Advertisement
More documents for Agilent (Group)
- [1] Agilent Technologies Inc.. (5/11/26). "Press Release: Agilent to Participate in Jefferies Global Healthcare Conference". Santa Clara, CA....
- [2] Agilent Technologies Inc.. (4/14/26). "Press Release: Agilent Partners with OmixAI to Expand AI-Driven Proteomics in South Korea". Seoul....
- [3] Agilent Technologies Inc.. (4/2/26). "Press Release: Agilent Opens Customer Experience Center in Mumbai". Navi Mumbai....
- [4] Agilent Technologies Inc.. (3/11/26). "Press Release: Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States". Santa Clara, CA....
- [5] Agilent Technologies Inc.. (3/9/26). "Press Release: Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions". Santa Clara, CA & San Francisco, CA....
- [6] Agilent Technologies Inc.. (2/25/26). "Press Release: Agilent Reports First-Quarter Fiscal Year 2026 Financial Results". Santa Clara, CA....
- [7] Agilent Technologies Inc.. (2/23/26). "Press Release: Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference". Santa Clara, CA....
- [8] Agilent Technologies Inc.. (2/11/26). "Press Release: Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)". Santa Clara, CA....
- [9] Agilent Technologies Inc.. (2/11/26). "Press Release: Agilent Presents Boehringer Ingelheim with Inaugural 2025 Instrument Trade-In Impact Award". Santa Clara, CA....
- [10] Agilent Technologies Inc.. (2/4/26). "Press Release: Agilent Showcases Next-Generation Automated Solutions at SLAS2026". Santa Clara, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top



![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)




![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)


